| Name | Title | Contact Details |
|---|
DesignAxiom Ltd. is a Toronto, ON-based company in the Software & Internet sector.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
See related links to what you are looking for.
Your success is our business. We exist to ensure that your business grows and prospers. Through our work with the community and state and federal government, we foster a vibrant business environment that allows our members to thrive.
Signature Seismic is a Calgary, AB-based company in the Software & Internet sector.